Professional attitudes toward the use of neuromodulatory technologies in Mexico: Insight for neuroethical considerations of cultural diversity
CNS Spectr
.
2022 Jun;27(3):255-257.
doi: 10.1017/S1092852920002151.
Epub 2020 Dec 10.
Authors
Karen Herrera-Ferrá
1
2
,
Humberto Nicolini
1
3
,
James Giordano
2
4
Affiliations
1
Asociación Mexicana de Neuroética, Atizapán, State of Mexico, Mexico.
2
Neuroethics Studies Program, Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC, USA.
3
Lab. de Enfermedades Psiquiátricas, Neurodegenerativas y Adicciones, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.
4
Departments of Neurology and Biochemistry, Georgetown University Medical Center, Washington, DC, USA.
PMID:
33298232
DOI:
10.1017/S1092852920002151
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Attitude*
Cultural Diversity*
Humans
Mexico
Surveys and Questionnaires
Grants and funding
UL1 TR001409/TR/NCATS NIH HHS/United States